Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.40USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$1.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,058
52-wk High
$3.19
52-wk Low
$1.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.27 February 3 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 --
(2) OUTPERFORM 1 1 1 --
(3) HOLD 0 0 0 --
(4) UNDERPERFORM 0 0 0 --
(5) SELL 0 0 0 --
No Opinion 0 0 0 --
Mean Rating 2.00 2.00 2.00 --

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Feb-16 1 0.83 0.83 0.83 --
Year Ending Feb-17 1 0.04 0.04 0.04 0.55
Year Ending Feb-18 1 0.04 0.04 0.04 0.61
Earnings (per share)
Quarter Ending Feb-16 1 -0.27 -0.27 -0.27 --
Year Ending Feb-16 1 -1.00 -1.00 -1.00 --
Year Ending Feb-17 1 -0.74 -0.74 -0.74 -1.16
Year Ending Feb-18 1 -0.77 -0.77 -0.77 -1.16

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Nov-14 0.27 0.02 0.25 91.10
Earnings (per share)
Quarter Ending Nov-14 -0.27 0.25 0.52 -191.90

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Feb-16 0.83 -- -- -- --
Year Ending Feb-17 0.04 0.04 0.04 0.04 0.55
Year Ending Feb-18 0.04 0.04 0.04 0.04 0.61
Earnings (per share)
Quarter Ending Feb-16 -0.27 -- -- -- --
Year Ending Feb-16 -1.00 -- -- -- --
Year Ending Feb-17 -0.74 -0.74 -0.74 -0.74 -1.16
Year Ending Feb-18 -0.77 -0.77 -0.77 -0.77 -1.16

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Feb-16 -- -- -- --
Year Ending Feb-17 0 0 0 0
Year Ending Feb-18 0 0 0 0
Earnings
Quarter Ending Feb-16 -- -- -- --
Year Ending Feb-16 -- -- -- --
Year Ending Feb-17 0 0 0 0
Year Ending Feb-18 0 0 0 0